Lung Health Research Grants | Breathe PA

Lung Health Research Grants

Funding Research That Supports Our Mission

Breathe PA provides grant funding for research projects that support our mission to help western Pennsylvanians breathe better and live healthier.

We issue annual request for proposals (RFPs) for the purpose of conducting research leading to improved care and outcomes for patients with lung disease. Funding is made available to individuals, groups, and institutions committed to improving health outcomes for individuals with lung and respiratory disease. Funding announcements will be made at the end of June.

2025 Lung Health Research Grant: Request for Proposals (RFP)

NOW OPEN: Accepting Applications Through May 2, 2025

Breathe PA is issuing a request for proposals (RFP) to conduct research leading to improved care and outcomes for patients with lung disease.

In 2025, Breathe PA will fund two tracks of research, each focused on improving the lung health of western Pennsylvania:

  1. Clinical Research
  2. Social Innovations

The clinical research track will concentrate on studying lung health to enhance medical knowledge and improve patient care and experiences. Meanwhile, the social innovations track will focus on creating and implementing new processes, ideas, or organizational models to address social issues and improve the well-being of patients with lung disease.

Each track will have a separate grant issued for up to a maximum of $60,000 each, from July 1, 2025, to June 30, 2026. An applicant may apply for funding under one or both tracks but may only receive one grant.

We invite you or representatives from your organization to apply for Breathe PA’s Lung Health Research Grant. This grant supports our organization’s pursuit of improving the quality of life for those suffering from respiratory diseases and preventing respiratory diseases in future generations in Western Pennsylvania.

Applicants must complete this application and submit by email to Casey Monroe, Breathe PA Executive Director, at cmonroe@breathepa.org by May 2, 2025, for funding considerations. Breathe PA will not accept late applications, nor any other form or version of this application. Resumes and/or CVs for the project team are required for the grant submission to be considered complete. Please attach these to the application.

NOTE: Applicants shall not include personally identifiable health care information in any application materials.

The selected applicants shall be required to enter into a formal Grant Agreement with Breathe PA upon notification of award. The Grant Agreement will include standard terms and conditions as determined by Breath PA, which may include but are not limited to provisions on deliverables, reporting requirements, funding disbursement, and compliance with applicable laws and regulations. The applicant agrees to comply with all terms set forth in the Grant Agreement as a condition of receiving the grant funding.

If you have any questions or require more information, please contact Casey by email or phone: 412-807-8661.

2025 Lung Health Research Grant RFP

Headshot of Dr. Tariq Cheema

2024-2025 Grantee

Evaluating the Efficacy of AVAPS versus BiPAP in Managing COPD Exacerbations

Author: Tariq Cheema, MD, FCCP, MMM

Abstract: This project aims to evaluate the effectiveness of Average Volume Assured Pressure Support (AVAPS) versus Bi-level Positive Airway Pressure (BiPAP) in managing Chronic Obstructive Pulmonary Disease (COPD) exacerbations. Chronic Obstructive Pulmonary Disease is a significant global health issue, with high morbidity, healthcare utilization, and associated costs. Non-invasive ventilation (NIV) strategies like AVAPS and BiPAP have shown promise in reducing mortality, intubation rates, hospital stay durations, and complications. This study will prospectively compare these modalities in a real-world setting to determine their impact on patient-reported outcomes, adherence rates, hospital readmission rates, and gas exchange metrics. The research will involve a comprehensive multidisciplinary team and a detailed methodology incorporating randomization, monitoring, and evaluation of key metrics. The expected outcomes include identifying the most effective NIV device for managing and preventing COPD exacerbations, thereby enhancing patient care and outcomes. This study’s findings could significantly influence clinical practice, offering evidence-based guidance on the optimal NIV strategy, improving patient outcomes, and reducing healthcare costs.

Make a Donation

Make a Donation

Your tax-deductible donation funds education and support for people with lung disease and their caregivers.

Make a Donation